Attached files

file filename
EX-99.2 - Lineage Cell Therapeutics, Inc.ex99-2.htm
EX-32 - Lineage Cell Therapeutics, Inc.ex32.htm
EX-23.3 - Lineage Cell Therapeutics, Inc.ex23-3.htm
10-K/A - Lineage Cell Therapeutics, Inc.form10-ka.htm

 

Exhibit 31

 

CERTIFICATIONS

I, Michael D. West, certify that:

 

1. I have reviewed this annual report on Form 10-K/A of BioTime, Inc.
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

Date: April 2, 2018  
     
/s/ Michael D. West    
Michael D. West    
Co-Chief Executive Officer    

 

   
 

 

Exhibit 31

 

CERTIFICATIONS

I, Aditya Mohanty, certify that:

 

1. I have reviewed this annual report on Form 10-K/A of BioTime, Inc.
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

Date: April 2, 2018  
   
/s/ Aditya Mohanty    
Aditya Mohanty    
Co-Chief Executive Officer    

 

   
 

 

Exhibit 31

 

CERTIFICATIONS

I, Russell Skibsted, certify that:

 

1. I have reviewed this annual report on Form 10-K/A of BioTime, Inc.
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

Date: April 2, 2018  
 
/s/ Russell Skibsted  
Russell Skibsted    
Chief Financial Officer